Opdivo, also known as nivolumab, represents a groundbreaking advancement in malignancy care. It's a class of biological therapy, specifically a monoclonal antibody, designed to boost your body's natural responses combat malignant cells. Unlike traditional treatments that kill cancer cells, Opdivo